Want to see HK:0809 full AI Analyst Report?
0809 Stock Chart & Stats
HK$0.06
>-HK$0.01(-1.00%)
At close: 4:00 PM EST
HK$0.06
>-HK$0.01(-1.00%)
Day’s Range― - ―
52-Week RangeHK$0.31 - HK$1.22
Previous CloseN/A
Volume370.00K
Average Volume (3M)8.43M
Market Cap
HK$688.26M
Enterprise ValueHK$2.20B
Total Cash (Recent Filing)HK$94.44M
Total Debt (Recent Filing)HK$1.79B
Price to Earnings (P/E)2.9
Beta0.10
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.14
Shares Outstanding1,683,277,100
10 Day Avg. Volume3,078,640
30 Day Avg. Volume8,433,551
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)-1.36
Price to Sales (P/S)0.31
P/FCF Ratio-24.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Product Mix & End MarketsGlobal Bio-chem sells a range of corn-derived products (notably lysine), food additives and other biochemicals across animal feed, food and industrial markets. This diversified end-market exposure supports structural demand and reduces reliance on any single sector, helping revenue resilience over months.
Manufacturing Scale And Operational FootprintA workforce of ~1,890 implies a meaningful manufacturing and operational footprint in corn processing and amino-acid production. Established production capacity and experienced operations increase the company's ability to meet customer contracts, maintain product quality and recover throughput within a multi-month horizon.
Historical Revenue Growth CapabilityReported historical revenue growth near 14% indicates the company has previously expanded sales and market penetration. Despite recent volatility, this track record suggests commercial capability to grow volumes or regain lost sales over a medium-term window when market or price conditions normalize.
Bears Say
Negative Shareholders' Equity And High LeveragePersistent negative equity and substantial debt (~HK$1.8B) materially constrain financial flexibility. This structural over-leverage raises refinancing and covenant risks, limiting capacity for capital spending, strategic investments or buffer against cyclical shocks in the coming months.
Weak And Inconsistent Cash GenerationOperating cash flow and free cash flow recently turned negative, reversing prior periods of positive cash generation. Inconsistent cash conversion undermines the company's ability to service debt, fund working capital and invest in operations without relying on external financing over the medium term.
Poor Core Profitability And Volatile RevenueRevenue volatility (sharp 2025 decline) combined with negative EBIT and thin gross margins point to weak core operating economics. Reliance on non-operating items for reported net income reduces earnings quality and limits sustainable profit generation over the next several months.
Global Bio-chem Technology Group Co. Ltd. News
0809 FAQ
What was Global Bio-chem Technology Group Co. Ltd.’s price range in the past 12 months?
Global Bio-chem Technology Group Co. Ltd. lowest stock price was HK$0.31 and its highest was HK$1.22 in the past 12 months.
What is Global Bio-chem Technology Group Co. Ltd.’s market cap?
Global Bio-chem Technology Group Co. Ltd.’s market cap is HK$688.26M.
When is Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date?
Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 38 days.
How were Global Bio-chem Technology Group Co. Ltd.’s earnings last quarter?
Global Bio-chem Technology Group Co. Ltd. released its earnings results on Mar 27, 2026. The company reported HK$0.319 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.319.
Is Global Bio-chem Technology Group Co. Ltd. overvalued?
According to Wall Street analysts Global Bio-chem Technology Group Co. Ltd.’s price is currently Overvalued.
Does Global Bio-chem Technology Group Co. Ltd. pay dividends?
Global Bio-chem Technology Group Co. Ltd. pays a Semiannually dividend of HK$0.2 which represents an annual dividend yield of N/A. See more information on Global Bio-chem Technology Group Co. Ltd. dividends here
What is Global Bio-chem Technology Group Co. Ltd.’s EPS estimate?
Global Bio-chem Technology Group Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Bio-chem Technology Group Co. Ltd. have?
Global Bio-chem Technology Group Co. Ltd. has 1,683,277,100 shares outstanding.
What happened to Global Bio-chem Technology Group Co. Ltd.’s price movement after its last earnings report?
Global Bio-chem Technology Group Co. Ltd. reported an EPS of HK$0.319 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.503%.
Which hedge fund is a major shareholder of Global Bio-chem Technology Group Co. Ltd.?
Currently, no hedge funds are holding shares in HK:0809
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Global Bio-chem Technology Group Co. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.23%
12-Months-Change
Fundamentals
Return on Equity
-11.47%
Trailing 12-Months
Asset Growth
1.69%
Trailing 12-Months
Company Description
Global Bio-chem Technology Group Co. Ltd.
Global Bio-chem Technology Group Company Limited, an investment holding company, manufactures and sells corn refined products and corn-based biochemical products in the People's Republic of China, Asia, the Americas, and internationally. It operates through four segments: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company offers corn refined products, including corn oil, corn steep liquor, corn starch, waxy corn starch, corn gluten meals, feed pellets, and corn germ cakes. It also provides downstream corn based biochemical products, such as amino acids comprising lysine, protein lysine, threonine, and glutamic acid; corn sweeteners, which include high fructose corn syrup, maltodextrin, high maltose syrup, maltose syrup, sorbitol, glucose, and crystallized glucose; modified starches; and chemicals, such as ethylene, propylene, and butylene glycols, as well as resins. In addition, the company offers polyol chemicals, anti-freeze products, hydrogen, and ammonia. Its products are used in various applications, such as feed production, food and beverage, cosmetics, textiles, pharmaceuticals, chemical industries, etc. The company was founded in 1994 and is headquartered in Hung Hom, Hong Kong.
Technical Analysis
Global Sweeteners Holdings Limited
―
Natural Food International Holding Ltd.
―
Vedan International (Holdings) Ltd.
―
China Starch Holdings Limited
―
Asia Cassava Resources Holdings Limited
―